Skip To Main Content
Larysa J. Sanchez on Muck Rack

Larysa J. Sanchez

As seen in: Nature, Wiley Online Library, ONCOLOGY journal, OncLive, Oncology Nursing News, Patient Power
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Larysa J.

Contact Larysa J., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma

|
By Darren Pan, Tarek H. Mouhieddine, Tianxiang Sheng, Weijia Fu, Erin Moshier, Joshua Richter, Samir Parekh, Sundar Jagannath, Ajai Chari, Adriana Rossi, Larysa J. Sanchez, César Rodríguez Verified, Hearn J. Cho, Shambavi Richard, Santiago Thibaud
| Nature Verified
Although chimeric antigen receptor (CAR) T cell therapy is highly efficacious in relapsed/refractory multiple myeloma (RRMM), both durations of remissions and toxicities can be highly variable underscoring the need for better biomarkers. Interactions between CAR T cells and host inflammatory milieu plays a significant role in CAR T cell activation and expansion, efficacy, and toxicity [1, 2].
Open in Who Shared Issue with article?

Impact of T-cell Affinity in Bispecific Therapy in R/R MM

|
By Ajai Chari, Noopur Raje, Rafael Fonseca, Larysa J. Sanchez
| ONCOLOGY journal Verified
October 4, 2024 By Noopur Raje, MD, discusses the role of T-cell affinity in bispecific therapy for patients with relapsed/refractory multiple myeloma and how it impacts treatment practices.
Open in Who Shared View Duplicates (6) Issue with article?

Overview of RedirecTT-1, MagnetisMM-30 and MagnetisMM-5

|
By Ajai Chari, Noopur Raje, Rafael Fonseca, Larysa J. Sanchez
| ONCOLOGY journal Verified
September 27, 2024 By Noopur Raje, MD, reviews clinical research on elranatamab combination therapy in patients with relapsed/refractory multiple myeloma.
Open in Who Shared View Duplicates (6) Issue with article?
See all 31 licensed articles (52 Total)